JPRN-UMIN000037029
Completed
未知
Identification of biomarkers which reflects the treatments effects of Nivolmab through comprehensive analyses of serum exosmal mRNA derived from the HNSCC patients. - Identification of biomarkers which reflects the treatments effects of Nivolmab through comprehensive analyses of serum exosmal mRNA derived from the HNSCC patients.
Clinical Research Support Center Kyushu0 sites111 target enrollmentJune 17, 2019
Conditionshead and neck squamous cell cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- head and neck squamous cell cancer
- Sponsor
- Clinical Research Support Center Kyushu
- Enrollment
- 111
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients who have been given immune checkpoint inhibitors in the past. 2\.Patients with ECOG Performance Status 3 or 4 3\.Patients under tumor immunotherapy or with plan to be co\-administered with other antineoplastic agents. 4\.Patients with active double cancer excluding CIS and endoscopically treatable early esophagus cancer. 5\.patients judged inappropriate by investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Identification of biomarkers specific to different nicotine product categoriessmokingDRKS00022428ABF GmbH60
Recruiting
Not Applicable
Identification of biomarker and clarification of resistance mechanism in immune checkpoint inhibitor therapyon-small cell lung cancer Kidney cancer Malignant melanoma Classical Hodgkin's lymphoma Head and neck cancer Gastric cancer Urothelial cancer Microsatellite instability-high (MSI-H) solid tumorJPRN-UMIN000027091Kanagawa Cancer Center Research Institute560
Completed
Not Applicable
Identification of biomarkers, functional parameters and clinical risk factors predisposing for the development of pulmonary chronic GVHD after allogeneic hematopoietic stem cell transplantation.obliterative bronchiolitis, bronchiolitis obliterans with organizing pneumonia (BOOP), non-classifiable interstitial pneumonia (NCIP)chronic GVHD, ICD-10: T86.05, T86.06, T86.07T86.06DRKS00003304Westdeutsches TumorzentrumKlinik für KnochenmarktransplantationUniversitätsklinikum Essen125
Recruiting
Not Applicable
Identification of Bio-Markers Predicting the Therapeutic Effects of Tocilizumab in Rheumatoid ArthritisRheumatoid ArthritisJPRN-UMIN000012005Osaka Medical College40
Recruiting
Not Applicable
Identification of biomarkers for diagnosis and prognosis in the patients with obstructive sleep apneaobstructive sleep apneaJPRN-UMIN000021503Osaka university graduate School of medicine The department of geriatric and general medicine200